Back to Rankings

QURE

uniQureA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-16
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
QURE vs peer average
84/100
QURE vs. peer average (A vs. C)
Grade spread
A 2 · B 2 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CAPR is the first available peer comparator.

Capricor is the closest packet peer for small-cap clinical/regulatory biotech risk, though modality and disease focus differ; it is more useful as a catalyst-volatility benchmark than a direct valuation read-through peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCAPRCapricor Therapeutics
QURE
uniQure
CAPR
Capricor Therapeutics
Grade
A
D
Momentum
91
31
Value
41
41
Sentiment
55
72
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs CAPR

QURE / CAPR
Grade Position
Above peers
QURE vs. peer average (A vs. C)
84/100
Momentum
91
QURE
Value
41
QURE
Sentiment
55
CAPR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs QURE
1
CAPR
CAPR
D
40/100
+3
2
AGIO
AGIO
F
20/100
+4
3
ZYME
Zymeworks Inc Common
D
40/100
+3
4
RAPP
Rapport Therapeutics Inc Common
B
80/100
+1
5
GENB
Generate Biomedicines Inc Common
N/A
-
-
CAPR is the first peer returned for this comparison set.